Style | Citing Format |
---|---|
MLA | Momtazmanesh S, et al.. "Novel Variants of Dock8 Deficiency in a Case Series of Iranian Patients." Endocrine# Metabolic and Immune Disorders - Drug Targets, vol. 22, no. 1, 2022, pp. 159-168. |
APA | Momtazmanesh S, Rayzan E, Zoghi S, Shahkarami S, Molatefi R, Mohammadzadeh I, Ghaffari J, Mahmoudi H, Dmytrus J, Segarraroca A, Somekh I, Witzel M, Hauck F, Boztug K, Klein C, Rezaei N (2022). Novel Variants of Dock8 Deficiency in a Case Series of Iranian Patients. Endocrine# Metabolic and Immune Disorders - Drug Targets, 22(1), 159-168. |
Chicago | Momtazmanesh S, Rayzan E, Zoghi S, Shahkarami S, Molatefi R, Mohammadzadeh I, Ghaffari J, et al.. "Novel Variants of Dock8 Deficiency in a Case Series of Iranian Patients." Endocrine# Metabolic and Immune Disorders - Drug Targets 22, no. 1 (2022): 159-168. |
Harvard | Momtazmanesh S et al. (2022) 'Novel Variants of Dock8 Deficiency in a Case Series of Iranian Patients', Endocrine# Metabolic and Immune Disorders - Drug Targets, 22(1), pp. 159-168. |
Vancouver | Momtazmanesh S, Rayzan E, Zoghi S, Shahkarami S, Molatefi R, Mohammadzadeh I, et al.. Novel Variants of Dock8 Deficiency in a Case Series of Iranian Patients. Endocrine# Metabolic and Immune Disorders - Drug Targets. 2022;22(1):159-168. |
BibTex | @article{ author = {Momtazmanesh S and Rayzan E and Zoghi S and Shahkarami S and Molatefi R and Mohammadzadeh I and Ghaffari J and Mahmoudi H and Dmytrus J and Segarraroca A and Somekh I and Witzel M and Hauck F and Boztug K and Klein C and Rezaei N}, title = {Novel Variants of Dock8 Deficiency in a Case Series of Iranian Patients}, journal = {Endocrine# Metabolic and Immune Disorders - Drug Targets}, volume = {22}, number = {1}, pages = {159-168}, year = {2022} } |
RIS | TY - JOUR AU - Momtazmanesh S AU - Rayzan E AU - Zoghi S AU - Shahkarami S AU - Molatefi R AU - Mohammadzadeh I AU - Ghaffari J AU - Mahmoudi H AU - Dmytrus J AU - Segarraroca A AU - Somekh I AU - Witzel M AU - Hauck F AU - Boztug K AU - Klein C AU - Rezaei N TI - Novel Variants of Dock8 Deficiency in a Case Series of Iranian Patients JO - Endocrine# Metabolic and Immune Disorders - Drug Targets VL - 22 IS - 1 SP - 159 EP - 168 PY - 2022 ER - |